Abstract:Brain tumor segmentation is an important technique in computer-assisted diagnosis. To improve brain tumor diagnosis, it is necessary to use biochemical information provided by magnetic resonance spectroscopy (MRS). Some of the challenges involved are determining how to combine multimodal signals such as proton MRS and morphological or structural images, then knowing how to use the combined information to make a decision. In this paper, we propose using a data fusion method to perform an automatic segmentation of the brain tumor areas. To diagnose brain tissue abnormalities such as tumors, we need to use multispectral magnetic resonance images (MRIs), e.g. T1-weighted, T2-weighted, gadolinium, or FLAIR to determine some properties of the tumor, including size, position, sort, and relationship with other tissues. However, the tumor type and grade are usually diagnosed from histopathological examination of a surgical specimen. Proton (1H) magnetic resonance spectroscopy (MRS) is a non invasive MR technique that provides biochemical information about metabolites. The major biochemical characteristics can provide useful information about brain tumor type and grade (Howe et al., 2003a; 2003b). In many studies, the use of in vivo 1H-MRS has been described for determining tumor type and grade (Howe et al., 2003a; Howe et al., 2003b; Preul et al., 1996; Majos et al., 2009). Since analysis of in vivo MRS measurements are dependent on acquisition techniques that could compromise the spatial resolution and accuracy of resulting metabolite values (Maudsley et al., 2009), metabolic changes associated with disease are frequently small and diffuse. Furthermore, using the chemical-shift imaging (CSI) technique, metabolite images, known as MR spectroscopic imaging (MRSI) images, can be created using multivoxel MRS information, but it is not as visually interpretable as in a structural MRI (Maudsley et al., 2009). So, for tumor tissue classification, it is important that MRSI be combined with MRI to make a more accurate estimation of variations in metabolites, support hypotheses of metabolite variation causes, and to yield sufficient information about the tissue. For over a decade, scientists have been developing automated brain-tumor classification methods using MRS (Garcia-Gomez et al., 2009), but a more clear definition of brain tumor type and grade may be obtained by combining MRS or MRSI and MRI (Garcia-Gomez et al., 2009). A technique used to differentiate glioblastoma from metastatic lesions using MRI and

Data Analysis and Tissue Type Assignment for Glioblastoma Multiforme.

Hierarchical non-negative matrix factorization (hNMF): a tissue pattern differentiation method for glioblastoma multiforme diagnosis using MRSI.

Glial Tumors: Quantification and Segmentation from MRI and MRS

Identification of Novel Human Glioblastoma-Specific Transcripts by Serial Analysis of Gene Expression Data Mining

A Distinction of Gliomas at Cellular and Tissue Level by Surface-Enhanced Raman Scattering Spectroscopy

Quantitative Analysis of Mean Apparent Propagator-Magnetic Resonance Imaging for Distinguishing Glioblastoma from Solitary Brain Metastasis

Identifying spatial imaging biomarkers of glioblastoma multiforme for survival group prediction.

Glioma Tissue Modeling by Combing the Information of MRI and in Vivo Multivoxel MRS

Histogram Analysis Based on Neurite Orientation Dispersion and Density MR Imaging for Differentiation Between Glioblastoma Multiforme and Solitary Brain Metastasis and Comparison of the Diagnostic Performance of Two ROI Placements

Invariant Delineation of Nuclear Architecture in Glioblastoma Multiforme for Clinical and Molecular Association

Identifying the Margin of Glioma Using 1H-MRSI Data

Unsupervised Nosologic Imaging for Glioma Diagnosis

Radiomic texture analysis based on neurite orientation dispersion and density imaging to differentiate glioblastoma from solitary brain metastasis

Towards MIB-1 and P53 Detection in Glioma Magnetic Resonance Image: a Novel Computational Image Analysis Method.

Machine-learning-based Classification of Glioblastoma Using MRI-based Radiomic Features.

Path-03. Spatial-Resolved Metabolomics Analysis In Histological And Molecular Glioblastomas Using A Mof/Mxene-Assisted Ldi-Msi Platform

Towards personalized diagnosis of Glioblastoma in Fluid-attenuated inversion recovery (FLAIR) by topological interpretable machine learning

The Feasibility of MRI Texture Analysis in Distinguishing Glioblastoma, Anaplastic Astrocytoma and Anaplastic Oligodendroglioma

Molecular Bases of Morphometric Composition in Glioblastoma Multiforme

Automatic Classification of Brain Tumor by in Vivo MRS Data Based on LDA and SVM

Identification and Analysis of Glioblastoma Biomarkers Based on Single Cell Sequencing